Drug class
Programmed Death Receptor-1 Blocking Antibody
Mechanism of action
Programmed Death Receptor-1-directed Antibody Interactions
General use cases
- Esophageal Squamous Cell Carcinoma
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
